La médecine génomique en santé internationale : le rôle des projets internationaux de science ouverte en génomique
Some therapeutic applications of genomic medicine are likely to lead to considerable improvement in the health care of developing countries in the coming years. However, the establishment of efficient innovation policies remains vital in order to ensure the progress of the genomic revolution. In the biomedical field, the commercialisation of the results of research has established itself as the dominant paradigm in the innovation system. However, many recent studies have demonstrated that this emphasis on commercialisation and the protection of intellectual property has led to deceiving results. Some stakeholders of the innovation system thus argue that it is now necessary to go beyond the commercialisation of research and implement policies based on the research valorisation paradigm, which supports the achievement of social as well as economic objectives. The objective of our thesis is to document the impact of international open science genomic medicine projects’ innovation policies on research and developement in genomics capacity building and access to genomic medicine in developing countries. We have thus developed a case study involving four international open science genomic medicine research projects. The results of our study have demonstrated that these projects play an important role in research and development in genomics capacity building in developing countries, but play a more limited role with regard to access to genomic medicine in these countries.
Valorisation Genomics Health Research and development Access Innovation policy Developing countries